A REVIEW OF AGO TUMOR

Molecular typing relies on molecular genetic tests and isn't but routinely out there. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-67 could possibly be beneficial, bu